Cargando…
Cryoprecipitate therapy
Cryoprecipitate, originally developed as a therapy for patients with antihaemophilic factor deficiency, or haemophilia A, has been in use for almost 50 yr. However, cryoprecipitate is no longer administered according to its original purpose, and is now most commonly used to replenish fibrinogen leve...
Autores principales: | Nascimento, B., Goodnough, L. T., Levy, J. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4627369/ https://www.ncbi.nlm.nih.gov/pubmed/24972790 http://dx.doi.org/10.1093/bja/aeu158 |
Ejemplares similares
-
Use of Cryoprecipitate in Newborn Infants
por: Tyagi, Manvi, et al.
Publicado: (2023) -
Factors affecting the quality of cryoprecipitate
por: Subramaniyan, Rajeswari, et al.
Publicado: (2017) -
Perioperative Cryoprecipitate Waste Reduction
por: Burk, Camden, et al.
Publicado: (2021) -
Cryoprecipitate as an alternative to platelet transfusion in thrombocytopenia
por: Crispin, Philip, et al.
Publicado: (2021) -
Initial Results of Empirical Cryoprecipitate Transfusion in the Treatment of Isolated Severe Traumatic Brain Injury: Use of In-house-produced Cryoprecipitate
por: SHIBAHASHI, Keita, et al.
Publicado: (2019)